Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | RAR-like nuclear receptor | 0.0063 | 0 | 0.5 |
Schistosoma mansoni | FTZ-F1 nuclear receptor-like protein | 0.0063 | 0 | 0.5 |
Trichomonas vaginalis | rheb, putative | 0.0264 | 1 | 0.5 |
Entamoeba histolytica | Ras family GTPase | 0.0264 | 1 | 0.5 |
Loa Loa (eye worm) | Ras protein let-60 | 0.0264 | 1 | 1 |
Schistosoma mansoni | thyroid hormone receptor | 0.0063 | 0 | 0.5 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0063 | 0 | 0.5 |
Trichomonas vaginalis | GTP-binding protein rit, putative | 0.0264 | 1 | 0.5 |
Entamoeba histolytica | ras-1, putative | 0.0264 | 1 | 0.5 |
Schistosoma mansoni | coup transcription factor | 0.0063 | 0 | 0.5 |
Schistosoma mansoni | photoreceptor-specific nuclear receptor related | 0.0063 | 0 | 0.5 |
Brugia malayi | Ras-related protein R-Ras2 | 0.0264 | 1 | 1 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0063 | 0 | 0.5 |
Onchocerca volvulus | 0.0063 | 0 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0264 | 1 | 1 |
Trichomonas vaginalis | ras-dva small GTPase, putative | 0.0264 | 1 | 0.5 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0063 | 0 | 0.5 |
Trichomonas vaginalis | ral, putative | 0.0264 | 1 | 0.5 |
Schistosoma mansoni | nuclear hormone receptor | 0.0063 | 0 | 0.5 |
Echinococcus multilocularis | ras gtpase | 0.0264 | 1 | 1 |
Echinococcus granulosus | ras gtpase | 0.0264 | 1 | 1 |
Schistosoma mansoni | steroid hormone receptor ad4bp | 0.0063 | 0 | 0.5 |
Schistosoma mansoni | nuclear receptor 2DBD-gamma | 0.0063 | 0 | 0.5 |
Entamoeba histolytica | Ras family GTPase | 0.0264 | 1 | 0.5 |
Schistosoma mansoni | thyroid hormone receptor | 0.0063 | 0 | 0.5 |
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.0063 | 0 | 0.5 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0063 | 0 | 0.5 |
Trichomonas vaginalis | rap1 and, putative | 0.0264 | 1 | 0.5 |
Schistosoma mansoni | nuclear hormone receptor nor-1/nor-2 | 0.0063 | 0 | 0.5 |
Schistosoma mansoni | Tr4/Tr2 (homologue) | 0.0063 | 0 | 0.5 |
Trichomonas vaginalis | dexras1, putative | 0.0264 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Decrease (functional) | = 39.8 % | Percent decrease in serum cholesterol relative to OVX controls, at 0.01 mg/Kg compound dose | ChEMBL. | 9548817 |
Decrease (functional) | = 65.5 % | Percent decrease in serum cholesterol relative to OVX controls, at 1.0 mg/Kg compound dose | ChEMBL. | 9548817 |
ED50 (functional) | = 0.7 mg kg-1 | Dose required to reduce serum cholesterol by 50% relative to ovariectomized(OVX) controls | ChEMBL. | 9548817 |
IC50 (functional) | = 80 nM | Inhibition of estrogen-stimulated MCF-7 cell proliferation | ChEMBL. | 9548817 |
IC50 (functional) | = 80 nM | Inhibition of estrogen-stimulated MCF-7 cell proliferation | ChEMBL. | 9548817 |
MED (functional) | = 0.1 mg kg-1 | Minimally effective dose(MED) (mg/kg body weight) at which a statistically significant (p<= 0.05) increase in uterine weight/body weight was observed | ChEMBL. | 9548817 |
MED (functional) | = 0.1 mg kg-1 | Minimally effective dose(MED) (mg/kg body weight) at which a statistically significant (p<= 0.05) increase in uterine weight/body weight was observed | ChEMBL. | 9548817 |
MED (functional) | > 10 mg kg-1 | Minimally effective dose(MED) (mg/kg body weight) at which a significant increase in EPO activity was observed in rats | ChEMBL. | 9548817 |
RBA (binding) | = 0.01 | Relative binding affinity of Estrogen receptor measured by using [3H]-17-beta-estradiol | ChEMBL. | 9548817 |
RBA (binding) | = 0.01 | Relative binding affinity to estrogen receptor | ChEMBL. | 22405286 |
RBA (binding) | = 0.01 | Relative binding affinity of Estrogen receptor measured by using [3H]-17-beta-estradiol | ChEMBL. | 9548817 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 9548817 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.